These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 367589)

  • 21. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
    Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
    Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunologic detection of primary carcinoma of the pancreas.
    Taguchi K
    Can J Surg; 1978 Jul; 21(4):313-5. PubMed ID: 354762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer.
    Rutherford JC; Walters BA; Cavaye G; Halliday WJ
    Int J Cancer; 1977 Jan; 19(1):43-8. PubMed ID: 319065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunodiagnosis of pancreatic cancer.
    Goldrosen MH; Campagnari A; Howell JH; Harvey S; Jenkins D; Berjian R; Douglass HO
    Prog Clin Biol Res; 1983; 133():167-82. PubMed ID: 6226048
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cancers transplanted in nude mice retain the expression of their organ-specific neoantigens.
    Thomson DM; Neville AM; Phelan K; Scanzano RS; Vandevoorde JP
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1191-7. PubMed ID: 7199466
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunodiagnosis of colorectal cancers by the leukocyte adherence inhibition test].
    Hudák J; Máriafoldy E; Nagy A; Szabó I; Baradnay G; Varga L
    Orv Hetil; 1983 Aug; 124(34):2045-7. PubMed ID: 6355968
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
    Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of the leukocyte adherence inhibition test in rectocolonic cancers].
    Bara J; Poupon MF
    Gastroenterol Clin Biol; 1984 Oct; 8(10):733-5. PubMed ID: 6396146
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
    Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
    Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM; Grosser N
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic oncofoetal antigen in pancreatic cancer.
    Hobbs JR; Branfoot AC; Knapp ML
    Practitioner; 1980 Oct; 224(1348):1023-7. PubMed ID: 7220429
    [No Abstract]   [Full Text] [Related]  

  • 40. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition.
    Thomson DM; Tataryn DN; Lopez M; Schwartz R; MacFarlane JK
    Cancer Res; 1979 Feb; 39(2 Pt 2):638-43. PubMed ID: 83918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.